Medicinal product name Braftovi
Pharmaceutical form Capsule, hard
Strength 50 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.II onk. ķīm. ter., hem.)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01EC03 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28
(50 mg)
PA/Al/PVC/Al blister    EU/1/18/1314/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/18/1314/001
Date of authorisation Sep 19, 2018
Marketing authorisation holder, country Pierre Fabre Medicament, France